Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 19 2025
0mins
Source: Globenewswire
Collaboration Announcement: Alpha Teknova, Inc. and Pluristyx, Inc. have partnered to exclusively offer the PluriFreeze™ cryopreservation system, enhancing the development of cell therapies with synthetic, animal-origin-free products designed for optimal cell viability.
Product Availability: The PluriFreeze system, which includes PluriFreeze Base and PF10, is now available for purchase, with options for research-grade and GMP-grade formulations, aimed at streamlining the manufacturing process from research to commercialization.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
